Evolving understanding of the immunopathogenesis of HIV : Tenth anniversary perspectives on AIDS : clinical investigation of HIV diseaseSAAG, M. S.AIDS research and human retroviruses. 1994, Vol 10, Num 8, pp 887-892, issn 0889-2229Conference Paper

What to do when zidovudine failsSAAG, M. S.The New England journal of medicine. 1994, Vol 330, Num 10, pp 706-707, issn 0028-4793Article

Azole antifungal agents: emphasis on new triazolesSAAG, M. S; DISMUKES, W. E.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 1, pp 1-8, issn 0066-4804Article

Gastrointestinal complications of HIV infection : changing priorities in the HAART eraWILCOX, C. M; SAAG, M. S.Gut. 2008, Vol 57, Num 6, pp 861-870, issn 0017-5749, 10 p.Article

Use of virologic markers in clinical practiceSAAG, M. S.Journal of acquired immune deficiency syndromes and human retrovirology. 1997, Vol 16, pp S3-S13, issn 1077-9450, SUP1Conference Paper

The infectious etiology of chronic rheumatic diseasesSAAG, M. S; BENNETT, J. C.Seminars in arthritis and rheumatism. 1987, Vol 17, Num 1, pp 1-23, issn 0049-0172Article

Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Editorial responseSPEED, B; DUNT, D; SAAG, M. S et al.Clinical infectious diseases. 1995, Vol 21, Num 1, pp 28-36, issn 1058-4838Article

Treatment of histoplasmosis and blastomycosisSAAG, M. S; DISMUKES, W. E.Chest. 1988, Vol 93, Num 4, pp 848-851, issn 0012-3692Article

Lessons Learned From the Design and Implementation of Myocardial Infarction Adjudication Tailored for HIV Clinical CohortsCRANE, H. M; HECKBERT, S. R; MUGAVERO, M. J et al.American journal of epidemiology. 2014, Vol 179, Num 8, pp 996-1005, issn 0002-9262, 10 p.Article

Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain-triglyceride-containing formulaCRAIG, C. B; DARNELL, B. E; SAUBERLICH, H. E et al.Journal of the American Dietetic Association. 1997, Vol 97, Num 6, pp 605-611, issn 0002-8223Article

A short-term clinical evaluation of L-697,661, a non-nucleoside-inhibitor of HIV-1 reverse transcriptaseSAAG, M. S; EMINI, E. A; ANDERSON, K. W et al.The New England journal of medicine. 1993, Vol 329, Num 15, pp 1065-1072, issn 0028-4793Article

High-level viremia in adults and children infected with human immunodeficiency virus : relation to disease stage and CD4⁺ lymphocyte levelsSAAG, M. S; CRAIN, M. J; DON DECKER, W et al.The Journal of infectious diseases. 1991, Vol 164, Num 1, pp 72-80, issn 0022-1899, 9 p.Article

In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosaLYON, M. D; SMITH, K. R; SAAG, M. S et al.Antimicrobial agents and chemotherapy. 1986, Vol 30, Num 1, pp 25-30, issn 0066-4804Article

Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9)CRANE, P. K; GIBBONS, L. E; WILLIG, J. H et al.AIDS Care (Print). 2010, Vol 22, Num 7, pp 874-885, issn 0954-0121, 12 p.Article

Correlation between circulating stromal cell-derived factor 1 levels and CD4⁺ cell count in human immunodeficiency virus type 1-infected individualsDERDEYN, C. A; COSTELLO, C; KILBY, J. M et al.AIDS research and human retroviruses. 1999, Vol 15, Num 12, pp 1063-1071, issn 0889-2229Article

Calmodulin antagonists inhibit apoptosis of CD4⁺ T-cells from patients with AIDSPAN, G; TONG ZHOU; RADDING, W et al.Immunopharmacology (New York). 1998, Vol 40, Num 2, pp 91-103, issn 0162-3109Article

Combination chemotherapy for human immunodeficiency virus-1. DiscussionMANION, D. J; HIRSCH, M. S; BARTLETT, J. G et al.The American journal of medicine. 1997, Vol 102, Num 5B, pp 76-80, issn 0002-9343Article

Viral dynamics in human immunodeficiency virus type 1 infectionXIPING WEI; GHOSH, S. K; SAAG, M. S et al.Nature (London). 1995, Vol 373, Num 6510, pp 117-122, issn 0028-0836Article

Stability in the HIV vDNA pool in peripheral CD4 + T cells of untreated patients by single tube quantitative PCRHOCKETT, R. D; SAAG, M. S; KILBY, J. M et al.Journal of virological methods. 2000, Vol 87, Num 1-2, pp 1-12, issn 0166-0934Article

Antiretroviral therapy in adults : Updated recommendations of the International AIDS Society-USA PanelCARPENTER, C. C. J; COOPER, D. A; RICHMAN, D. D et al.JAMA, the journal of the American Medical Association. 2000, Vol 283, Num 3, pp 381-390, issn 0098-7484Article

Practice guidelines for the management of cryptococcal diseaseSAAG, M. S; GRAYBILL, R. J; LARSEN, R. A et al.Clinical infectious diseases. 2000, Vol 30, Num 4, pp 710-718, issn 1058-4838Article

Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adultsSAAG, M. S; SONNERBORG, A; TORRES, R. A et al.AIDS (London). 1998, Vol 12, Num 16, pp F203-F209, issn 0269-9370Article

Antiretroviral therapy for HIV infection in 1997 : Updated recommendations of the International AIDS Society-USA panelCARPENTER, C. C. J; FISCHL, M. A; THOMPSON, M. A et al.JAMA, the journal of the American Medical Association. 1997, Vol 277, Num 24, pp 1962-1969, issn 0098-7484Article

Candidate antiretroviral agents for use in postexposure prophylaxisSAAG, M. S.The American journal of medicine. 1997, Vol 102, Num 5B, pp 25-31, issn 0002-9343Article

Pharmacokinetics of anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjectsRUIWEN ZHANG; JIEMING YAN; SCHECHTER, P. J et al.Clinical pharmacology and therapeutics. 1995, Vol 58, Num 1, pp 44-53, issn 0009-9236Article